For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Geron Corporation

USPTO Granted Patents = 198

% Expired Patents = 30.3

CIPO Patents = 15

EPO Patents = 37

Forward Citations = 3,947

Loading Chart...

Loading Chart...

142 inventors (with patents filed for the assignee):

Sergei M Gryaznov (36 out of 84 patents)

William H Andrews (33 out of 55 patents)

Gregg B Morin (30 out of 37 patents)

4. Calvin B Harley (30 out of 47 patents)

5. Krisztina Pongracz (26 out of 28 patents)

6. Melissa K Carpenter (19 out of 32 patents)

7. Thomas R Cech (19 out of 42 patents)

8. Joachim Lingner (19 out of 26 patents)

9. Toru M Nakamura (17 out of 24 patents)

10. Karen B Chapman (17 out of 33 patents)

11. Ronald A Pruzan (15 out of 15 patents)

12. Walter D Funk (14 out of 21 patents)

13. Chunhui Xu (14 out of 17 patents)

14. Joseph D Gold (14 out of 24 patents)

15. Bryant Villeponteau (14 out of 16 patents)

Core Competencies:

Telomerase Inhibitors

Oligonucleotide Compositions

Myeloproliferative Neoplasms

Cancer Treatment

RNAi

Guanine Analogs

Hematological Cancers

Stem Cell Culturing

Neural Progenitor Cells

Differentiation Protocols

C-myc Antisense Oligonucleotides

Quantitative PCR

198 patents: Sort by Forward Citations

1. 12698254 - Crystalline solids of 3-palmitoyl-amido-1,2-propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethylether-propane and methods of making and using the same (2026-08-04),

2. 12442000 - Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms (2025-10-14),

3. 12398162 - Guanine analogs as telomerase substrates and telomere length affectors (2025-08-26),

4. 12391946 - Use of a Janus kinase inhibitor and a telomerase inhibitor for the treatment of myeloproliferative neoplasms (2025-08-19),

5. 12264174 - Process for preparing imetelstat (2025-04-01),

6. 12201645 - Methods of treating myelodysplastic syndrome (2025-01-21),

7. 12171778 - Methods of treating myelodysplastic syndrome (2024-12-24),

8. 12122735 - Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1- (protected hydroxy)-propane salts and methods of making the same (2024-10-22),

9. 11987540 - Crystalline solids of 3-palmitoyl-amido-1,2-propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethylether-propane and methods of making and using the same (2024-05-21),

10. 11739114 - Oligonucleotide compositions and methods of making the same (2023-08-29),

11. 11530179 - Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1 -(protected hydroxy)-propane salts and methods of making the same (2022-12-20),

12. 11441144 - Methods of polynucleotide preparation using multivalent cation salt compositions (2022-09-13),

13. 11332489 - Process for preparing imetelstat (2022-05-17),

14. 11299511 - Oligonucleotide compositions and methods of making the same (2022-04-12),

15. 11279720 - Guanine analogs as telomerase substrates and telomere length affectors (2022-03-22),

Geron Corporation is a biotechnology company focused on developing therapies that can extend and improve the lives of cancer patients. The company's mission is to discover and develop first-in-class therapeutic products based on telomerase research and other proprietary technologies. Geron's primary focus is on developing imetelstat, a telomerase inhibitor, for multiple types of cancers. By targeting telomerase, Geron aims to disrupt cancer cell proliferation and induce cancer cell death. The company also pursues collaborations with academic institutions and industry partners to advance its research and development efforts. Geron Corporation is committed to advancing innovative therapies that address unmet medical needs in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Geron Corporation

198 Patents

#7 in Menlo Park, CA

#455 in California

#2,081 in US

#4,257 in the World

Menlo Park, CA, United States of America

Geron Corporation

Forward Citations = 3,947

142 inventors:

Sergei M Gryaznov (36 out of 84 patents)

William H Andrews (33 out of 55 patents)

Gregg B Morin (30 out of 37 patents)

4. Calvin B Harley (30 out of 47 patents)

5. Krisztina Pongracz (26 out of 28 patents)

Please report any incorrect information to [email protected]

Loading…